BUND FINANCE › Stocks › HIMS
Hims & Hers Health, Inc. (HIMS)
NYSE · Stock price, chart and technical analysis
Data from Financial Modeling Prep · Nov 18, 2026, 4:00 PM New York time · may be delayed
Key stats
Quick technical read
- Price is -37.35% below its 50-day average.
- It is -35.88% below its 200-day average (long-term downtrend).
- It sits at 12% of its 52-week range (0% = low, 100% = high).
This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it
Fundamentals Annual
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | US$271.9M | US$526.9M | US$872.0M | US$1.5B | US$2.3B |
| Net income | −US$107.7M | −US$65.7M | −US$23.5M | US$126.0M | US$128.4M |
| EPS (diluted) | -0.58 | -0.32 | -0.11 | 0.53 | 0.51 |
| Gross margin | 75.2% | 77.6% | 82.0% | 79.5% | 73.8% |
| Operating margin | -42.3% | -13.0% | -3.4% | 4.2% | 4.5% |
| Net margin | -39.6% | -12.5% | -2.7% | 8.5% | 5.5% |
| Free cash flow | −US$39.4M | −US$33.8M | US$47.0M | US$198.3M | US$74.0M |
| Total debt | US$5.5M | US$5.3M | US$9.9M | US$11.3M | US$1.1B |
| Cash | US$71.8M | US$46.8M | US$96.7M | US$220.6M | US$228.6M |
Compound annual growth: revenue 71.4% · net income — (4 years).
Valuation: today, its history and its sector
| Today | 5-year average | Sector median (Healthcare) | |
|---|---|---|---|
| P/E | — | 49.3x | 27.1x |
| EV / EBITDA | — | 51.2x | 16.5x |
| Operating margin | -6.0% | — | 3.6% |
| Net margin | -6.7% | — | -0.0% |
| Debt / equity | 8.98 | — | 0.58 |
Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, bioti…
Other stocks on BUND FINANCE
Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice